BeOne Medicines and CAVA report Q3 results: sales up, profit diverges
BeOne Medicines lifted revenue to $1.89B and CAVA to $356.44M, but CAVA's net income fell. Figures from 10-Q filings, as summarized by TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, citing SEC filings, BeOne Medicines' third-quarter 2026 revenue reached $1.89B, up 33.8% from a year earlier. Net income rose to $384.71M, and diluted EPS came in at $0.25. BRUKINSA sales grew 33.7% and TEVIMBRA sales grew 27.6%.
CAVA's revenue climbed 22% to $356.44M, while net income fell 10.5% to $13.2M. The chain reached 500 restaurants, and same-restaurant sales rose 3.1%. Diluted EPS was $0.11 versus $0.12 a year earlier, weighed down by restaurant operating costs, pre-opening expenses and growth investments.
why it matters
Investors will note the different profit trends: BeOne's revenue is outpacing its R&D spending, and its product gross margin rose to 88.3%. CAVA's sales growth did not offset higher operating costs, which makes its bottom line look weaker despite the top-line gain.
market impact
BeOne Medicines: revenue and profit growth supports the shares; CAVA: lower net income weighs on the stock.
- BeOne Medicines shares pressure up — revenue and net income grew much faster than a year earlier
- CAVA shares pressure down — net income fell 10.5% even though revenue rose 22%
tags
instruments
sources
- BeOne Medicines 3Q 2026: Revenue $1.89B, EPS $0.25 — 10-Q Summary — TradingView, 5 November 2026 at 11:11 UTC
- CAVA 3Q 2026: Revenue $356.44M, EPS $0.11 — 10-Q Summary — TradingView, 5 November 2026 at 11:11 UTC
- Tapestry 3Q 2026: Revenue $1.89B, EPS $1.76 — 10-Q Summary — TradingView, 5 November 2026 at 11:51 UTC
- Unity 3Q 2026: Revenue $622.09M, EPS $0.25 — 10-Q Summary — TradingView, 5 November 2026 at 12:21 UTC
- Airship AI 3Q 2026: Revenue $6.23M, EPS $0.25 — 10-Q Summary — TradingView, 5 November 2026 at 14:11 UTC
- Callaway Golf 3Q 2026: Revenue $436.9M, EPS $0.25 — 10-Q Summary — TradingView, 5 November 2026 at 22:21 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗